Results · Apr-Jun 2026 · filed 11 Aug 2026
EPL Q1 FY27 results
Sales grew 25% to ₹1,388 crore from ₹1,108 crore in Apr-Jun 2025.
Operating profit grew 15% to ₹261 crore, an operating margin of 18.8% (down 1.7 points from a year ago).
Net profit fell 1% to ₹101 crore from ₹101 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +7%, net profit −3%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 1,388 | 1,108 | +25% |
| Operating profit (EBITDA) | 261.2 | 226.8 | +15% |
| Operating margin | 18.8% | 20.5% | −1.7 pts |
| Net profit | 100.6 | 101.4 | −1% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
EPL delivered 25.3% revenue growth & 15.2% EBITDA growth in Apr–Jun 2026, with underlying 20% revenue growth excluding pass-through pricing. Management raised full-year revenue guidance to high teens while maintaining 20% underlying EBITDA margins, citing strong momentum in Beauty & Cosmetics & Oral Care recovery.
The last 7 quarters
Filings that week
- 12 Aug 2026Newspaper Publication With Respect To The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended On June 30, 2026
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 11 Aug 2026Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended On June 30, 2026
- 11 Aug 2026Board Meeting Outcome for Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended On June 30, 2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.